These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1429688

  • 1. A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis.
    Michaeli J, Busquets X, Orlow I, Younes A, Colomer D, Marks PA, Rifkind RA, Kolesnick RN.
    J Biol Chem; 1992 Nov 25; 267(33):23463-6. PubMed ID: 1429688
    [Abstract] [Full Text] [Related]

  • 2. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
    Michaeli J, Lebedev YB, Richon VM, Chen ZX, Marks PA, Rifkind RA.
    Mol Cell Biol; 1990 Jul 25; 10(7):3535-40. PubMed ID: 1972544
    [Abstract] [Full Text] [Related]

  • 3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA.
    Prog Clin Biol Res; 1989 Jul 25; 316B():171-81. PubMed ID: 2616574
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.
    Melloni E, Pontremoli S, Viotti PL, Patrone M, Marks PA, Rifkind RA.
    J Biol Chem; 1989 Nov 05; 264(31):18414-8. PubMed ID: 2808382
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.
    Richon VM, Weich N, Leng L, Kiyokawa H, Ngo L, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1666-70. PubMed ID: 1672043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX.
    Zhonghua Zhong Liu Za Zhi; 1991 Jul 01; 13(4):261-4. PubMed ID: 1806345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
    Paoletti F, Vannucchi AM, Mocali A, Caporale R, Burstein SA.
    Blood; 1995 Oct 01; 86(7):2624-31. PubMed ID: 7670106
    [Abstract] [Full Text] [Related]

  • 12. Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation.
    Leng L, Yu F, Dong L, Busquets X, Osada S, Richon VM, Marks PA, Rifkind RA.
    Cancer Res; 1993 Nov 15; 53(22):5554-8. PubMed ID: 8221697
    [Abstract] [Full Text] [Related]

  • 13. Calcium influx in induced differentiation of murine erythroleukemia cells.
    Gillo B, Ma YS, Marks AR.
    Blood; 1993 Feb 01; 81(3):783-92. PubMed ID: 7678999
    [Abstract] [Full Text] [Related]

  • 14. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM, Rifkind RA, Marks PA.
    Cell Growth Differ; 1992 Jul 01; 3(7):413-20. PubMed ID: 1419904
    [Abstract] [Full Text] [Related]

  • 15. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 01; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
    Murate T, Kaneda T, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1984 Jun 01; 81(11):3394-8. PubMed ID: 6203120
    [Abstract] [Full Text] [Related]

  • 19. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 20. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG, Ikeda K, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1986 Sep 01; 83(18):6849-53. PubMed ID: 3462732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.